about
IL-1α reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy?Anti-RAGE antibody ameliorates severe thermal injury in rats through regulating cellular immune function.Endothelial dysfunction and renal fibrosis in endotoxemia-induced oliguric kidney injury: possible role of LPS-binding protein.Computational approaches for translational clinical research in disease progression.New approaches to the study of sepsisDynamic changes of circulating T-helper cell subsets following severe thoracic trauma.Serum cytokines associated with severity and complications of kala-azar.Translating the role of vitamin D3 in infectious diseases.Microparticles and acute lung injury.Modulation of Dietary Lipid Composition During Acute Respiratory Distress Syndrome: Systematic Review and Meta-Analysis.Emerging role of Lipopolysaccharide binding protein in sepsis-induced acute kidney injury.Dissociation of ACTH and cortisol in septic and non-septic ICU patients.Acute inflammatory response to transgastric natural orifice transluminal endoscopic surgery peritoneoscopy: an experimental study in swine.Immunosedation: a consideration for sepsis.Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic Shock.Plasma glycation levels are associated with severity in sepsis.The immunomodulatory role of esmolol in patients undergoing laparoscopic gastrectomy due to gastric cancer.Effects of dexmedetomidine on inflammatory responses in patients undergoing laparoscopic cholecystectomy.Pharmacological inhibition of the triggering receptor expressed on myeloid cells-1 limits reperfusion injury in a porcine model of myocardial infarction.TLR4 inhibition impairs bacterial clearance in a therapeutic setting in murine abdominal sepsis.More of the Gut in the Lung: How Two Microbiomes Meet in ARDS.
P2860
Q33799514-5938FAA0-5031-4D55-A765-1E20C5AD9D86Q34138346-70798E22-5F5E-4067-B722-4B1C82856DECQ34381957-93A8F33B-19EC-4BD8-B272-07F2E35AE170Q35388120-5CB42AD8-079F-405E-892A-6E3984A6E267Q36492375-0D6EB400-2384-4CA7-8228-244BD95A432CQ36492982-519FD2F7-2278-4C31-8E9D-75444B43F336Q37726527-84EFE19C-FD32-4CB4-BA98-05F3F1FB1306Q37981255-95D75A1E-57A7-4074-A43C-37DE1C268D40Q38021265-3B8E7355-7D8D-4AAC-8E4A-D7DE8F83C964Q38308115-E03EB469-3486-43B2-9323-A520AEA38BC2Q38888914-5F7FAFDE-A09F-4CE5-A209-BDF851E7CA14Q40609103-7A682030-C698-4C57-A373-44A6DA2DB365Q41808918-D80381AA-1648-425A-BA72-D68EBDB33CD5Q41857623-F821EA37-9F5A-4A73-BA2D-0BDA805A0734Q47153305-A8D578B5-D99F-40E1-991C-1ED335816963Q47717872-F8633EAC-BE69-4520-B888-99F7381C28ABQ48004599-B0C47AF8-FE70-4E5E-8A2A-C650498B382BQ48107174-1C5C8E9D-6E84-41A3-B1F7-37C152A1A624Q53485739-15BC338D-CA9F-4CEB-BD8B-7F6C48F32D4FQ54283887-8F8C1C79-1FEC-4D0E-A703-E1C400C6C19EQ55356524-8A4EB9A6-7BDF-4FDB-94EB-1542D4E745EE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunomodulation in the critically ill.
@en
Immunomodulation in the critically ill.
@nl
type
label
Immunomodulation in the critically ill.
@en
Immunomodulation in the critically ill.
@nl
prefLabel
Immunomodulation in the critically ill.
@en
Immunomodulation in the critically ill.
@nl
P356
P1476
Immunomodulation in the critically ill.
@en
P2093
H F Galley
N R Webster
P356
10.1093/BJA/AEP128
P407
P577
2009-05-27T00:00:00Z